Overview

Naproxen Sodium ER Pharmacokinetic Study

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
To determine the pharmacokinetic profile of the investigational product following dosing under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Naproxen